[SRNE] QoQ Quarter Result on 31-Dec-2013 [#Q4]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
31-Mar-2014
Financial Year
2013
Quarter
31-Dec-2013 [#Q4]
Profit Trend
QoQ- -236.59%
YoY- -543.65%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
Revenue 1,276 775 976 101 84 142 134 348.64%
PBT -7,605 -8,454 -10,093 -11,296 -3,356 -4,737 -2,522 108.58%
Tax 2 5 4 4 2 2 2 0.00%
NP -7,605 -8,454 -10,093 -11,296 -3,356 -4,737 -2,522 108.58%
Tax Rate - - - - - - - -
Total Cost 8,881 9,229 11,069 11,397 3,440 4,878 2,656 123.44%
Ratio Analysis
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
NP Margin -596.00 -1,090.84 -1,034.12 -11,217.68 -4,005.73 -3,345.11 -1,881.46 -53.49%
Per Share
30/09/14 30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 CAGR
EPS -0.27 -0.33 -0.44 -0.49 -0.24 -0.35 -0.20 22.12%
EPS Diluted -0.27 -0.33 -0.44 -0.49 -0.24 -0.35 -0.20 22.12%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.